FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic
223 outletsin 17 languages and 26 countriesFirst reported , latest

The FDA has mandated that safety labels for GLP-1 drugs include a warning about the potential risk of a rare eye condition known as NAION[1, 3–6, 9]. NAION, often referred to as an "eye stroke," occurs when blood flow to the optic nerve is reduced[1, 6]. The FDA issued this warning to ensure patients are aware of the potential risk, although the risk appears small and data is mixed[5, 6]. The FDA's action follows reports and studies indicating a possible link between GLP-1 drugs and vision loss[2–8, 10].
A language model wrote this brief from the reports below; the numbers link to them. Check the reports for anything that matters.
Told around the world
- ¿Usas medicamentos GLP-1? Esta es la advertencia sobre tu salud visual
- 《TAIPEI TIMES》 GLP-1 weight-loss drugs can cause blindness in rare cases, FDA warns
FDA warns that GLP-1 weight-loss drugs can cause blindness in rare cases.
- GLP-1 ilaçları için yeni bir görme kaybı uyarısı yayınlandı
New warning about vision loss for GLP-1 drugs
- Φάρμακα GLP-1: Νέα προειδοποίηση για σπάνια παρενέργεια που μπορεί να οδηγήσει σε απώλεια όρασης
GLP-1 drugs: New warning about rare side effect that may lead to vision loss
- 미국 FDA, 비만약 '시력 손상' 경고 문구 의무화...마운자로·위고비 등 GLP-1 전 계열 대상
People and organizations
Named in this story's headlines. Add any of them to CRM by Hottub; nothing is saved until you press Add there.
- United States Food and Drug AdministrationOrganizationAdd
Every report 300 reports
- FDA Requires Vision Loss Warnings On Labels Of GLP-1 Medications
iHeartRadioCA
Add to CRMAlso published by iHeartRadio, iHeartRadio, iHeartRadio, iHeartRadio, iHeartRadio, iHeartRadio, iHeartRadio, iHeartRadio, iHeartRadio, iHeartRadio and 34 more
- FDA adds rare vision-loss warning to popular GLP-1 drugs
Vincennes Sun-CommercialUS
Add to CRMAlso published by The Daily Courier, The Intelligencer & Wheeling News Register, KRCG, The Miami Times, KSLA, KXRM-TV, WSVN, WKTV, WRAL-TV, abcnews.com and 8 more
- GLP-1 drugs getting new labels warning of rare vision-loss condition
WOFLUS
Add to CRMAlso published by KSAZ-TV, KTVU, WTTG, WNYW, WFLD, fox5atlanta.com, fox4news.com


- Rare Eye Condition Prompts New FDA Warning on Popular GLP-1 Drugs
neurologyadvisor.com
Add to CRMAlso published by renalandurologynews.com, Medical Xpress
- Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
Kenya Broadcasting CorporationKE
Add to CRMAlso published by British Broadcasting Corporation, British Broadcasting Corporation

- FDA warns GLP-1 users of rare eye stroke risk as lawsuits emerge
KFVS-TVUS
Add to CRMAlso published by WOIO
- FDA Orders GLP-1 Label Warnings Over Potential Vision Loss Risk
KLIFUS
Add to CRMAlso published by KLIF-FM
- FDA Now Requiring GLP-1 Makers to Warn About Rare but Severe Eye Condition
WCBMUS
Add to CRMAlso published by Townhall
- 減肥神藥恐釀永久失明! 美FDA要求所有GLP-1藥物全面加註警語 | 國際
Newtalk NewsTW
Add to CRM - Предупреждение за риск за зрението от GLP-1 изиска FDA
Warning about vision risk from GLP-1 issued by FDA
puls.bgBG
Add to CRM
- FDA adds rare blindness warning to popular GLP-1 drugs
The IndependentGB
Add to CRM.jpg?auto=webp&trim=0%2C0%2C0%2C0&width=1200)
- FDA warns of potential vision loss risk linked to popular GLP-1 drugs
The News InternationalPK
Add to CRM 
